05:23 PM EDT, 10/04/2022 (MT Newswires) -- Donald A Bergstrom, President, R&D, on October 03, 2022, sold 8,000 shares in Relay Therapeutics (RLAY) for $179,440. Following the Form 4 filing with the SEC, Bergstrom has control over a total of 88,683 shares of the company, with 88,683 shares held directly. The market value of the direct and indirect holding, based on the transaction price, is approximately $1,989,160.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1812364/000120919122052221/xslF345X03/doc4.xml
Price: 25.7, Change: +1.68, Percent Change: +6.99